4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-17-043263
Options or other derivatives
- Director acquired 220,788 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Sigal Charles Elliott Director | 2017-07-03 | Grant or award · Option to purchase Ordinary Shares | +220,788 | 220,788 | D | ||
Loading xslF345X03/a4.xml…